1. Newsroom
Menu

Newsroom


Insight 14.01.2022

Towards a Net Zero Emissions Economy with Green Bonds

The market for green and social bond issued by financial and non-financial companies is booming.

Corporate 13.01.2022

UBP supports the performing arts with Comédie partnership

As UBP continues to support local cultural endeavours, we are pleased to announce our most recent project: a partnership with Comédie de Genève for the next three seasons.

Insight 11.01.2022

Emerging market fixed income: An asset class of choice for 2022

Despite waning global growth momentum and rising inflation, strong fundamentals and relative valuations are offering compelling arguments for a strategic allocation to emerging market fixed income.

Insight 06.01.2022

The pillars behind ‘Swiss-made’ excellence

Global consumers’ everyday lives are shaped by Swiss products and services at different levels and in various aspects. Our experts dive into the secret behind “Swiss-made” quality.

UBP in the press 03.01.2022

Finance is a booster for the green transition

Le Temps (27.12.2021) - One fact about the financial industry that everyone agrees on nowadays is that, as a strategic allocator of private capital, it has a major role to play in reducing economies’ carbon footprint, and this is clear to see in the sharp growth of so-called “sustainable” funds.

Insight 21.12.2021

UBP Asset Management (Europe) joins the Race to Zero

This month, UBP Asset Management (Europe) joined the Net Zero Asset Managers initiative, reflecting its commitment to supporting the transition to a net-zero future by mid-century.

Insight 16.12.2021

Investing amidst the inflection in the fed policy cycle

The surge in inflation in 2021 combined with the sharp fall in unemployment leaves two of the US Federal Reserve’s key policy objectives within reach as the year comes to a close.

Press Releases 15.12.2021

UBP joins forces with conservation experts to launch biodiversity restoration strategy

UBP announced a step forward in its commitment to impact investing with the launch of a biodiversity restoration strategy in a unique collaboration between the financial, corporate and conservation sectors.


Insight 10.12.2021

Reshaping the European Union

The global pandemic has allowed the European Union to lay a new foundation upon which it can build to bring about greater integration in the years ahead.

UBP in the press 03.12.2021

"The Web consumer is king"

La Regione (29.11.2021) - The year that is about to end has been marked not only by the persistence of health alarms linked to the coronavirus pandemic, but also by a strong economic recovery in the United States and Europe, chiefly driven by the gradual reopening underpinned by the advancement of vaccination campaigns.

Corporate 02.12.2021

UBP sheds light on the biodiversity-investment nexus

As part of Building Bridges Week – the agenda-setting event on sustainable finance taking place in Geneva from 29 November to 2 December 2021 – UBP hosted an interactive panel discussion on biodiversity and its investment opportunities.

Insight 26.11.2021

The strong performance potential of Swiss small and mid-cap equities

The Swiss small- and mid-cap (also known as “SMID-cap”) universe offers a balanced and diversified exposure to companies with long-term value-creation potential. Active managers can create significant added value through a disciplined stock-selection process.

UBP in the press 24.11.2021

The quest for returns in a zero-rate world

Funds People (17.11.2021) - The rise of passive management, the difficulty of finding profitable, low-risk investments in a context of 0% interest rates, industry concentration and the ESG boom are just some of the challenges asset managers face. We spoke to Nicolas Faller, Co-CEO of Asset Management at Union Bancaire Privée, about all of this and more, in an exclusive interview. 

Insight 22.11.2021

CRISPR: the implications of gene editing

In the latest episode of UBP’s Expert series, Norman Villamin, CIO Wealth Management and Pierre Corby, Equity Analyst Healthcare, invited Dr Samarth Kulkarni, CEO of CRISPR Therapeutics, to discuss the challenges and investment opportunities offered by medical innovation, specifically in the field of gene editing.

Insight 19.11.2021

UBP Investment Outlook 2022

Embracing Change

UBP in the press 18.11.2021

Is inflation a real concern for credit markets?

Institutional Money (8.11.2021) - Coming into the final quarter of the year, our view had been that the economic recovery would allow central banks to start guiding towards less accommodative policies, and that this would provide room for rates to rise.